US 9358240
Treprostinil administration by inhalation
granted A61KA61K31/192A61K31/557
Quick answer
US patent 9358240 (Treprostinil administration by inhalation) held by United Therapeutics Corporation expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/192, A61K31/557, A61K9/0078, A61K9/008